Preliminary results of the neratinib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGhT): A phase II platform trial using bayesian adaptive randomization Meeting Abstract

  

Authors:	Arrillaga-Romany, I.; Trippa, L.; Fell, G.; Lee, E. Q.; Rahman, R.; Touat, M.; McCluskey, C.; Bruno, J.; Gaffey, S.; Drappatz, J.; Lassman, A.; Galanis, E.; Ahluwalia, M.; Colman, H.; Nabors, L. B.; Hepel, J.; Elinzano, H.; Kaley, T.; Mellinghoff, I. K.; Schiff, D.; Chukwueke, U.; Beroukhim, R.; Nayak, L.; McFaline-Figueroa, J. R.; Batchelor, T.; Lu-Emerson, C.; Bi, W. L.; Arnaout, O.; Peruzzi, P.; Haas-Kogan, D.; Tanguturi, S.; Cagney, D.; Aizer, A.; Welch, M.; Doherty, L.; Lavallee, M.; Fisher-Longden, B.; Dowling, S.; Geduldig, J.; Watkinson, F.; Santagata, S.; Meredith, D.; Chiocca, E. A.; Reardon, D.; Ligon, K.; Alexander, B.; Wen, P.
Abstract Title:	Preliminary results of the neratinib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGhT): A phase II platform trial using bayesian adaptive randomization
Meeting Title:	26th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title:	Neuro-Oncology
Volume:	23
Issue:	Suppl. 6
Meeting Dates:	2021 Nov 18-21
Meeting Location:	Boston, MA
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2021-11-01
Start Page:	vi59
Language:	English
ACCESSION:	WOS:000757356200232
PROVIDER:	wos
DOI:	10.1093/neuonc/noab196.230
Notes:	Meeting Abstract: CTNI-05 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/193523